Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807
- PMID: 38592321
- PMCID: PMC10932066
- DOI: 10.3390/jcm13051479
Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807
Abstract
In the original publication [...].
Erratum for
-
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study.J Clin Med. 2023 Sep 6;12(18):5807. doi: 10.3390/jcm12185807. J Clin Med. 2023. PMID: 37762747 Free PMC article.
References
-
- van Veelen A., Küçük I.T., Fuentes F.H., Kahsay Y., García-García H.M., Delewi R., Beijk M.A.M., Den Hartog A.W., Grundeken M.J., Vis M.M., et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023;12:5807. doi: 10.3390/jcm12185807. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
